Skip to Main Content

Paper Details

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Breast Cancer Research and Treatment
29
2019
AURKA, Aurora A, BT474, BT474 xenograft model, ER, FRAX1036, HER2, MAPK kinase, PAK, PAK1, alisertib, breast cancer, breast tumor, breast tumors, cell lines, estrogen, estrogen receptor alpha, human, human breast tumor cell lines, luminal, luminal and HER2-enriched, multiple, p21-activated kinase 1, serine, serine-threonine kinases Aurora A, threonine, tumor, tumors
Author NameAffiliation
Erica A GolemisFox Chase Cancer Center
  • 1 - 1

Datasets

Release 1.2